Drugs · acquisition-cost intelligence
365 whole foods market ibuprofen
hydrocortisone, bacitracin zinc, neomycin sulfate, polymyxin b sulfate, Ibuprofen· ingredient ibuprofenAntiinflammatory preparations, non-steroids for topical use· IBUPROFEN 200 mg/1; IBUPROFEN 200 mg/1000mg
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per EA
$0.03227
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per EA — the trend nobody else shows. 7 weeks.
2025-12-172026-05-27
Same-ingredient options by acquisition cost
Other ibuprofen products, cheapest acquisition cost first. Per EA — confirm strength/form equivalence before switching.
| Product | NADAC / EA | vs this |
|---|---|---|
| basic care childrens ibuprofen | $0.03041 | −$0.00190 |
| IBU | $0.04428 | +$0.01200 |
| IBU | $0.05051 | +$0.01820 |
| IBU | $0.05674 | +$0.02450 |
| Advil | $0.08009 | +$0.04780 |
| basic care childrens ibuprofen | $0.15408 | +$0.12180 |
| basic care infants ibuprofen | $0.20097 | +$0.16870 |
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.